SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.110-7.7%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (457)3/30/2006 7:42:36 PM
From: Mike McFarlandRead Replies (1) of 557
 
Targeted Genetics
Biotech to seek reverse stock split

Targeted Genetics will ask shareholders to authorize a reverse stock split at the Seattle biotech company's annual meeting in May, according to a regulatory filing Wednesday.

The company seeks to combine its 98.5 million shares at a ratio of 1-for-5, 1-for-7 or 1-for-10 to raise the per-share price. Shares closed at 44 cents Wednesday and haven't been more than $1 since last April 15. A higher stock price could return the company to compliance with requirements for continued listing on the Nasdaq Capital Market.

archives.seattletimes.nwsource.com

yahoo.brand.edgar-online.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext